| 摘要 |
There is provided combination products comprising (a) ramatroban, or a ph armaceutically-acceptable salt or solvate thereof and (b) a statin, or a pha rmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related cond itions.
|
